Whole-Body MRI vs. PET/CT for the Detection of Bone Metastases in Patients With Prostate Cancer: A Systematic Review and Meta-Analysis

Whole-Body MRI vs. PET/CT for the Detection of Bone Metastases in Patients With Prostate Cancer: A Systematic Review and Meta-Analysis

Purpose: A recent meta-analysis in patients with non-small cell lung cancer showed no difference between whole-body magnetic resonance imaging (WBMRI) and positron emission tomography/computed tomography (PET/CT), but no such study is available for prostate cancer (PCa). This study aimed to compare...

Full description

Bibliographic Details
Main Authors:	Yuefu Zhan, Guangming Zhang, Mingliang Li, Xiaobo Zhou
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-05-01
Series:	Frontiers in Oncology
Subjects:	prostate cancer magnetic resonance imaging positron emission tomography computed tomography bone metastasis meta-analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2021.633833/full

Similar Items

A Challenging Case of Solitary Necrotic Nodules of the Liver Mimicking Hepatic Metastases: CT, MRI, and PET-CT Findings
by: Ji Yeon Hwang, et al.
Published: (2020-04-01)

Dynamic 11C-Choline PET / CT for the primary diagnosis of prostate cancer
by: Shay Golan, et al.

Performance of Ga-68 PSMA PET/CT for diagnosis and grading of local prostate cancer
by: Timothy N. Kwan, et al.
Published: (2021-06-01)

Staging in Patients with Small-Cell Lung Carcinoma; PET-CT versus Standard Staging Procedures
by: Burcu Yalçın, et al.
Published: (2016-12-01)

Impact of 68GA-PSMA PET / CT on treatment of patients with recurrent / metastatic high risk prostate cancer - a multicenter study
by: Aline B. Mattiolli, et al.

Diagnostic Performance of 68Gallium Labelled Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging for Staging the Prostate Cancer with Intermediate or High Risk Prior to Radical Prostatectomy: A Systematic Review and Meta-Analysis
by: Hui Wu, et al.
Published: (2020-04-01)

Is there the role of 18F-choline PET/CT in prostate cancer patients?
by: Hodolič Marina
Published: (2012-01-01)

Restaging the Biochemical Recurrence of Prostate Cancer with [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT: Diagnostic Performance and Impact on Patient Disease Management
by: Aloÿse Fourquet, et al.
Published: (2021-03-01)

A prospective study on dual time 18F-FDG-PET/CT in high-risk prostate cancer patients
by: Mike Allan Mortensen, et al.
Published: (2018-12-01)

Application Progress of 68Ga-PSMA PET/CT in Recurrent Prostate Cancer
by: YANG Liping, et al.
Published: (2018-07-01)

Dramatic polarization in genitourinary expert opinions regarding the clinical utility of positron emission tomography (PET) imaging in prostate cancer
by: Kiri A. Sandler, et al.

PET/CT in Multiple Myeloma: Beyond FDG
by: Federica Matteucci, et al.
Published: (2021-01-01)

Preoperative Screening CT and PET/CT Scanning for Acral Melanoma: Is it Necessary?
by: Taketoshi Ide, et al.
Published: (2021-02-01)

Prostate-specific membrane antigen positron emission tomography (PSMA-PET) for local staging of prostate cancer: a systematic review and meta-analysis
by: Sungmin Woo, et al.
Published: (2020-09-01)

Value of 11C-Choline PET/CT-Based Multi-Metabolic Parameter Combination in Distinguishing Early-Stage Prostate Cancer From Benign Prostate Diseases
by: Shuoming Zhou, et al.
Published: (2021-02-01)

Influence of X-ray computed tomography (CT) exposure and reconstruction parameters on positron emission tomography (PET) quantitation
by: Ivan Ho Shon, et al.
Published: (2020-10-01)

18 F-FDG PET-CT for Staging of Conjunctival Melanoma
by: Andres Damian, et al.
Published: (2013-01-01)

Pitfalls of FDG-PET in the prostate for the surgical oncologist
by: Ellen O'Connor, et al.
Published: (2020-11-01)

A Retrospective Comparative Study of Sodium Fluoride (NaF-18)-PET/CT and Fluorocholine (F-18-CH) PET/CT in the Evaluation of Skeletal Metastases in Metastatic Prostate Cancer Using a Volumetric 3-D Radiomics Analysis
by: Kalevi Kairemo, et al.
Published: (2021-12-01)

PET/CT: Current status in India
by: Venkatesh Rangarajan, et al.
Published: (2008-10-01)

Infrequent association between colon and prostate tumor, a clinico-radiological case
by: Alexander Sosa-Frias
Published: (2021-05-01)

11C-Choline-Avid but 18F-FDG-Nonavid Prostate Cancer with Lymph Node Metastases on Positron Emission Tomography
by: Kazuhiro Kitajima, et al.
Published: (2016-11-01)

PET/CT in thyroid carcinoma
by: Mihailović Jasna
Published: (2012-01-01)

Identification and characterization of myocardial metastases in neuroendocrine tumor patients using 68Ga-DOTATATE PET-CT
by: Wolfgang G. Kunz, et al.
Published: (2018-09-01)

Epididymal metastasis from prostate adenocarcinoma: An unusual and challenging diagnosis suspected in gallium-68 prostate-specific membrane antigen-positron emission tomography/computed tomography and histologically confirmed
by: Sofia Santos-Lopes, et al.
Published: (2017-01-01)

False-positive prostate cancer bone metastases on magnetic resonance imaging correctly classified on gallium-68-prostate-specific membrane antigen positron emission tomography computed tomography
by: Sofiullah Olayinka Abubakar, et al.
Published: (2018-01-01)

Trimodality PET/CT/MRI and Radiotherapy: A Mini-Review
by: Pierre Decazes, et al.
Published: (2021-02-01)

The added diagnostic value of complementary gadoxetic acid-enhanced MRI to 18F-DOPA-PET/CT for liver staging in medullary thyroid carcinoma
by: Daniel Puhr-Westerheide, et al.
Published: (2019-11-01)

Indirect comparison of the diagnostic performance of 18F-FDG PET/CT and MRI in differentiating benign and malignant ovarian or adnexal tumors: a systematic review and meta-analysis
by: Xianwen Hu, et al.
Published: (2021-10-01)

11C-Choline PET/CT and PSA kinetics
by: Castellucci Paolo, et al.
Published: (2012-01-01)

PET/CT in renal and bladder cancers
by: Balenović Antonija, et al.
Published: (2012-01-01)

Bone: From planar imaging to SPECT & PET/CT
by: Mihailović Jasna, et al.
Published: (2012-01-01)

Simultaneous PET/MRI: Impact on cancer management-A comprehensive review of cases
by: Amarnath Jena, et al.
Published: (2014-05-01)

PSMA PET for primary lymph node staging of intermediate and high-risk prostate cancer: an expedited systematic review
by: Lars J. Petersen, et al.
Published: (2020-01-01)

Malignancy Rate of Indeterminate Findings on FDG-PET/CT in Cutaneous Melanoma Patients
by: Ken Kudura, et al.
Published: (2021-05-01)

18 F sodium fluoride PET/CT in patients with prostate cancer: Quantification of normal tissues, benign degenerative lesions, and malignant lesions
by: Jorge D Oldan, et al.
Published: (2016-01-01)

Oligometastasis to testis in prostate cancer: Role of gallium-68 prostate-specific membrane antigen positron-emission tomography computed tomography
by: Manoj Gupta, et al.
Published: (2021-01-01)

Impact of F-18 Fluorodeoxyglucose PET/CT and PET/MRI on Initial Staging and Changes in Management of Pancreatic Ductal Adenocarcinoma: A Systemic Review and Meta-Analysis
by: Jeong Won Lee, et al.
Published: (2020-11-01)

PET-CT in oncology
by: Purandare N, et al.
Published: (2010-01-01)

Phase IIa Clinical Trial of Trans-1-Amino-3-18F-Fluoro- Cyclobutane Carboxylic Acid in Metastatic Prostate Cancer
by: Yusuke Inoue, et al.
Published: (2014-10-01)